publication venue for
- Risk of stroke with reduced dose direct oral anticoagulants vs standard dose anticoagulation after cardioversion of atrial fibrillation: A systematic review and meta-analysis.. 5:942-950. 2024
- A prospective, multicenter, randomized controlled trial comparing VDD-ICD with VVI-ICD in detecting subclinical atrial fibrillation in patients with ICDs: The Dx-AF trial.. 5:668-671. 2024
- Ventricular tachycardia risk prediction with an abbreviated duration mobile cardiac telemetry. 4:500-505. 2023
- Evidence gaps pertaining to high-risk medications: Commentary on anticoagulation in new-onset postoperative atrial fibrillation. 3:333-334. 2022
- Dose-limiting, adverse event–associated bradycardia with β-blocker treatment of atrial fibrillation in the GENETIC-AF trial. 3:40-49. 2022
- Prospective long-term follow-up of silicone-polyurethane–insulated implantable cardioverter-defibrillator leads. 3:57-64. 2022